California State Teachers Retirement System (CalSTRS)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-30,693
| Closed | -$3.13M | – | 3106 |
|
|
2023
Q2 | $3.13M | Sell |
30,693
-3,287
| -10% | -$311K | ﹤0.01% | 1229 |
|
|
2023
Q1 | $3.09M | Sell |
33,980
-418
| -1% | -$24.5K | ﹤0.01% | 1225 |
|
|
2022
Q4 | $1.31M | Buy |
34,398
+413
| +1% | +$14.2K | ﹤0.01% | 1740 |
|
|
2022
Q3 | $854K | Sell |
33,985
-663
| -2% | -$18.4K | ﹤0.01% | 1996 |
|
|
2022
Q2 | $1.05M | Buy |
34,648
+60
| +0.2% | +$1.79K | ﹤0.01% | 1923 |
|
|
2022
Q1 | $1.13M | Sell |
34,588
-2,880
| -8% | -$85.5K | ﹤0.01% | 1972 |
|
|
2021
Q4 | $988K | Buy |
37,468
+816
| +2% | +$63.1K | ﹤0.01% | 2170 |
|
|
2021
Q3 | $3.69M | Sell |
36,652
-1,185
| -3% | -$139K | ﹤0.01% | 1334 |
|
|
2021
Q2 | $5.36M | Sell |
37,837
-8,860
| -19% | -$1M | 0.01% | 1127 |
|
|
2021
Q1 | $4.66M | Buy |
46,697
+3,510
| +8% | +$409K | 0.01% | 1239 |
|
|
2020
Q4 | $5.34M | Buy |
43,187
+903
| +2% | +$119K | 0.01% | 1076 |
|
|
2020
Q3 | $4.12M | Buy |
42,284
+1,577
| +4% | +$197K | 0.01% | 1066 |
|
|
2020
Q2 | $6.35M | Buy |
40,707
+6,266
| +18% | +$953K | 0.01% | 836 |
|
|
2020
Q1 | $4.97M | Buy |
34,441
+281
| +0.8% | +$54.3K | 0.01% | 822 |
|
|
2019
Q4 | $6.98M | Buy |
34,160
+2,888
| +9% | +$527K | 0.01% | 838 |
|
|
2019
Q3 | $2.51M | Buy |
31,272
+322
| +1% | +$27.3K | ﹤0.01% | 1396 |
|
|
2019
Q2 | $2.92M | Buy |
30,950
+2,013
| +7% | +$174K | 0.01% | 1320 |
|
|
2019
Q1 | $2.47M | Sell |
28,937
-357
| -1% | -$29.6K | 0.01% | 1387 |
|
|
2018
Q4 | $1.64M | Buy |
29,294
+689
| +2% | +$42.1K | ﹤0.01% | 1602 |
|
|
2018
Q3 | $2.34M | Buy |
28,605
+4,269
| +18% | +$301K | ﹤0.01% | 1513 |
|
|
2018
Q2 | $851K | Buy |
24,336
+6,845
| +39% | +$208K | ﹤0.01% | 2151 |
|
|
2018
Q1 | $359K | Sell |
17,491
-434
| -2% | -$11.2K | ﹤0.01% | 2542 |
|
|
2017
Q4 | $508K | Sell |
17,925
-400
| -2% | -$11.2K | ﹤0.01% | 2398 |
|
|
2017
Q3 | $570K | Buy |
18,325
+3,200
| +21% | +$96.2K | ﹤0.01% | 2350 |
|
|
2017
Q2 | $479K | Buy |
15,125
+2,600
| +21% | +$63.9K | ﹤0.01% | 2492 |
|
|
2017
Q1 | $284K | Buy |
12,525
+800
| +7% | +$19.8K | ﹤0.01% | 2736 |
|
|
2016
Q4 | $256K | Sell |
11,725
-300
| -2% | -$7.59K | ﹤0.01% | 2812 |
|
|
2016
Q3 | $317K | Buy |
12,025
+100
| +0.8% | +$1.98K | ﹤0.01% | 2715 |
|
|
2016
Q2 | $236K | Buy |
+11,925
| New | +$232K | ﹤0.01% | 2860 |
|
Other funds holding RETA
California State Teachers Retirement System (CalSTRS)'s RETA Position: Q3 2023 in Review
California State Teachers Retirement System (CalSTRS) sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 30,693 shares — an estimated $3.13M sold.
California State Teachers Retirement System (CalSTRS) first reported a position in RETA in Q2 2016 and held it in 29 quarters. The position peaked at $6.98M in Q4 2019. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.
- California State Teachers Retirement System (CalSTRS) reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 30,693 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $3.13M.
- California State Teachers Retirement System (CalSTRS) first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2016 and held it in 29 quarters.
- California State Teachers Retirement System (CalSTRS)'s Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $6.98M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q3 2023, filed 14 Nov 2023.